Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Global Ocular Neuropathic Pain Market Growth 2023-2029
... the Ocular Neuropathic Pain is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research report highlights the growth potential of the global Ocular Neuropathic ... Read More
-
Omics-Based Clinical Trials Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... in the forecast period with a CAGR of 7.25% through 2028. Omics-based clinical trials are clinical research studies that incorporate omics technologies to gather comprehensive molecular data from patients participating in the trial. Omics refers ... Read More
-
Germany In Silico Clinical Trials Market
... broader landscape of clinical research and pharmaceutical development. In silico clinical trials, a relatively recent advancement, employ computational modeling and simulation techniques to expedite the drug development process, reduce costs, and minimize the need for ... Read More
-
Edema Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II), By Participant (Pediatrics, Adults), By Study Design (Interventional Trials, Observational Trials), By Type (Systemic Edema, Localized Edema), By Region, And S
... And Segment Forecasts, 2023 - 2030 Edema Clinical Trials Market Growth & Trends The global edema clinical trials market size is expected to reach USD 1.27 billion by 2030, registering a compound annual growth rate ... Read More
-
Global Merchant API Market (by Molecular Type, Segment, Type, Type of Synthesis, End-User, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)
... all activities related to the development and manufacture of active pharmaceutical ingredients (API) for both clinical trials and commercial products. Because of the expertise and equipment required to manufacture the compounds, there has been an ... Read More
-
HIV Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Sponsor (Pharmaceutical & Biopharmaceutical Companies, Non-Profit Organizations, Others), By Region, By Competition
... By Sponsor (Pharmaceutical & Biopharmaceutical Companies, Non-Profit Organizations, Others), By Region, By Competition Global HIV Clinical Trials Market has valued at USD 1.23 billion in 2022 and is anticipated to project impressive growth in the ... Read More
-
United States Pharmacovigilance Market By Clinical Trial Phase (Pre-Clinical, Phase 1, Phase 2, Phase 3, and Phase 4), By Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service Provider (In-House, Contract Outsourcing), By End User (Hospitals, Research Organizations, Industries), By Region, Competition, Forecast and& Opportunities, 2018-2028F
... Provider (In-House, Contract Outsourcing), By End User (Hospitals, Research Organizations, Industries), By Region, Competition, Forecast and& Opportunities, 2018-2028F United States Pharmacovigilance Market is anticipated to project steady growth in the forecast period. Pharmacovigilance, a vital ... Read More
-
U.S. Cell And Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis Report By Service (Site Identification, Patient Recruitment), By Phase (Phase I, Phase II), By Therapeutic Areas, By Therapy Type, And Segment Forecasts, 2024 - 2030
... Forecasts, 2024 - 2030 U.S. Cell And Gene Therapy Clinical Trial Services Market Growth & Trends The U.S. cell and gene therapy clinical trial services market is expected to reach USD 28.58 billion by 2030, ... Read More
-
Clinical Trials Market - Global Clinical Trials Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2030 -(By Phase Coverage, By Study Design Coverage, By Indication Coverage, By Service Type Coverage, By Geographic Coverage and Leading Companies)
... and Leading Companies) The global clinical trials market is on an impressive growth trajectory, with forecasts indicating a significant rise from its 2022 valuation of US$52.5 billion to an estimated US$79.9 billion by 2030. This ... Read More
-
Functional Service Providers (FSP) Market Research Report Forecast till 2027
... elements, including expanding Research and development ventures, the rising number of clinical preliminaries, and the ascent of FSP outsourcing in drug improvement. Rising Research and development speculations, particularly in the biopharmaceutical and biotechnology businesses, have ... Read More
-
Neurology Clinical Trials Market Report 2023-2033
... its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. The implementation of wearable devices, mobile health applications, ... Read More
-
Virtual Oncology Market, By Component (Software, Service, Hardware), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Others (Pancreatic, Ovarian, etc.)), By Application (Precision Medicine, Patient Care Management, Research & Development, Clinical Trials, Diagnosis & Treatment Decision Making, Data Management, Others (Billing Management, Regulatory Compliance etc.)), By End User (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract Research Organizations (CROs), Others (Reference Laboratories, Pharmacies etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... & Development, Clinical Trials, Diagnosis & Treatment Decision Making, Data Management, Others (Billing Management, Regulatory Compliance etc.)), By End User (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract ... Read More
-
HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... and drug resistance mechanisms. In 2022, the United States accounted for the maximum share of the total market of HER2-positive breast cancer in the 7MM was around 60%. The approval of HERCEPTIN marked a turning ... Read More
-
Blockchain in Drug Discovery and Clinical Trials Market, 2023-2035
... drugs and other pharmaceutical products, thereby reducing the prevalence of counterfeit drugs and medicine. The drug discovery process, which involves the identification of a relevant biological target and a corresponding pharmacological lead, is deemed crucial ... Read More
-
The 2023 Vaccine Market Report
... largely by the recent commercialization of the COVID-19 vaccine in the U.S. The U.S. vaccine market alone is projected to increase 47% from $23.8 billion in 2023 to $35.1 billion in 2030. Updated COVID-19 Vaccines ... Read More
-
Clinical Trial Management System Market Size, Share, and Analysis, By Type (Enterprise CTMS, On-Site CTMS), By Component (Software, Services), By Mode of Delivery (Cloud-Based CTMS, Web-Based CTMS, On-Premise CTMS), By End User (Pharmaceuticals, Clinical Research Organizations [CROs], Healthcare Providers), and Regional Forecasts, 2022-2032
... Organizations [CROs], Healthcare Providers), and Regional Forecasts, 2022-2032 PRODUCT OVERVIEW Clinical Trial Management System Market size was USD 1.26 billion in 2021 and projected to grow from USD 1.6 billion in 2023 to USD 5.0 ... Read More
-
Intrahepatic Cholangiocarcinoma- Pipeline Insight, 2023
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Intrahepatic ... Read More
-
Global Cancer Diagnostic Market - 2023-2030
... period 2023-2030. Molecular diagnostic techniques are rapidly used for cancer detection. It involves procedures for confirming specific types of cancer along with the tumor location, extent, and staging. Tissue biopsies are presently the gold standard ... Read More
-
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
... and opportunities, R&D strategies, pipeline assessment, and market outlook. Myasthenia Gravis (MG) is an autoimmune and neuromuscular disease that is characterized by muscle weakness and fatigue. In the majority of patients, the disease is initially ... Read More
-
South & Central America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The South & Central America clinical trials market is expected to grow from US$ 1,794.69 million in 2022 to US$ 2,523.98 million by 2028. It ... Read More
-
Middle East & Africa Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Middle East & Africa clinical trials market is expected to grow from US$ 1,524.94 million in 2022 to US$ 1,923.39 million by 2028. It ... Read More
-
North America Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The North America clinical trials market is expected to grow from US$ 27,322.28 million in 2022 to US$ 36,818.15 million by 2028. It is estimated to grow ... Read More
-
Europe Clinical Trials Market Forecast to 2028 - Regional Analysis - by Study Design (Interventional, Observational, and Expanded Access), Phase (Phase I, Phase II, Phase III, and Phase IV), and Indication (Autoimmune/Inflammation, Pain Management, Oncology, CNS Condition, Diabetes, Obesity, Cardiovascular, and Others)
... CNS Condition, Diabetes, Obesity, Cardiovascular, and Others) The Europe clinical trials market is expected to grow from US$ 15,739.35 million in 2022 to US$ 21,643.87 million by 2028. It is estimated to grow at a ... Read More
-
X-Linked Hypophosphatemic Rickets Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of X-Linked Hypophosphatemic Rickets Clinical trials scenario. This report provides top line data relating to the clinical trials on X-Linked Hypophosphatemic ... Read More
-
Spinocerebellar Ataxia (SCA) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Spinocerebellar Ataxia (SCA) Clinical trials scenario. This report provides top line data relating to the clinical trials on Spinocerebellar Ataxia ... Read More
Research Assistance
